drugset / Trial / NCT02853643
Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy Volunteers
RandomizedSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the safety and tolerability, and determine the blood levels (pharmacokinetics), in both a fed and fasted condition, of a single dose of ASN002. Healthy volunteers will be participants in the study.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-11
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gusacitinib | Small molecule | 25 mg | — |
| Subject | Gusacitinib | Small molecule | 50 mg | — |
| Subject | Gusacitinib | Small molecule | 100 mg | — |
Indications
No indication recorded.